The use of benchmark dose methodology with acute inhalation lethality data

Area of Science:

• Environmental Toxicology
• Risk Assessment Methodology
• Quantitative Structure-Activity Relationships (QSAR)

Background:

• Traditional health risk assessments rely on No Observed Adverse Effect Levels (NOAELs).
• Benchmark Dose (BMD) methodology offers a more refined approach.
• Inhalation toxicity data are crucial for establishing safe exposure limits.

Purpose of the Study:

• Compare Benchmark Concentration (BMC) estimates using probit and Weibull models.
• Evaluate BMCs at various response incidences (1%, 5%, 10%) against NOAELs and LOAELs.
• Assess the suitability of BMD methodology for acute lethality data.

Main Methods:

• Utilized 120 acute lethality datasets for inhalation toxicity studies.
• Applied log-normal probit and quantal Weibull models to estimate BMCs.
• Compared 95% Lower Confidence Limits (LCLs) of BMCs with NOAELs and LOAELs.

Main Results:

• The probit model demonstrated a better fit to the dose-response data compared to the Weibull model.
• Mean differences between 95% LCL BMCs and NOAELs were <2-fold (probit) and <4-fold (Weibull).
• BMC estimates at 10% response incidence sometimes exceeded observed LOAELs; 95% LCLs are crucial for safety.

Conclusions:

• Benchmark Dose modeling, particularly with the probit model, is a viable refinement for inhalation risk assessment.
• The 95% LCL of BMCs is essential for ensuring estimated safe concentrations remain below effect levels.
• Careful selection of response incidence is necessary, especially with steep dose-response curves.